C12N9/00

Methods of producing lipid-derived compounds and host cells thereof

The present disclosure relates to genetically engineered host cells and methods of producing a lipid-derived compound by employing such host cells. In particular embodiments, the host cell includes a first mutant gene encoding a cytoplasmic tRNA thiolation protein. Optionally, the host cell can include other mutant genes for decreasing fatty alcohol catabolism, decreasing re-importation of secreted fatty alcohol, or displaying other useful characteristics, as described herein.

RNA targeting methods and compositions

Provided herein are CRISPR/Cas methods and compositions for targeting RNA molecules, which can be used to detect, edit, or modify a target RNA.

Biochemical viscosity reducer for heavy oil and preparation method thereof

A biochemical viscosity reducer for heavy oil and a preparation method thereof. The viscosity reducer includes: Brevibacillus borstelensis-fermented mixed lipopeptide solution: 30 to 60 parts; compound biological enzyme: 15 to 30 parts; plant-based nonionic surfactant: 10 to 20 parts; antibacterial agent: 1 to 5 parts; stabilizer: 1 to 5 parts; and alcohol solvent: 10 to 20 parts; where, the above components are measured by mass. The preparation method includes: step 1: adding 30 to 60 parts of a Brevibacillus borstelensis-fermented mixed lipopeptide solution, 15 to 30 parts of a compound biological enzyme, 10 to 20 parts of a plant-based nonionic surfactant, and 1 to 5 parts of a stabilizer to a reactor; and step 2: adding 1 to 5 parts of an antibacterial agent and an alcohol solvent to the reactor, and stirring a resulting mixture for 60 min to 120 min.

MODULATION OF PROTEIN DEGRADATION
20230020607 · 2023-01-19 ·

Methods of assessing the efficacy of an agent in treating a disease or disorder are provided that include determining whether the agent causes, or inhibits, direct or indirect recruitment and/or ubiquitination and/or degradation of argininosuccinate synthetase 1 (ASS1).

RECOMBINANT VECTOR FOR TRANSFORMATION IMPROVING GLUTAMINE PRODUCTIVITY, AND STRAIN EMPLOYING SAME

The present invention relates to a strain which has increased glutamine productivity due to being transformed with a vector containing a nucleotide sequence that encodes a glutamine synthetase consisting of the amino acid sequence of SEQ ID NO: 1.

MODIFICATION OF HECT E3 UBIQUITIN LIGASE GENES TO IMPROVE YIELD TRAITS
20230016618 · 2023-01-19 ·

This invention relates to compositions and methods for modifying Homologous to E6AP C-Terminus (HECT) E3 Ubiquitin Protein Ligase (UPL) genes in plants, optionally to improve yield traits. The invention further relates to plants having increased improved yield traits produced using the methods and compositions of the invention.

Microbe having increased tolerance to phenolic fermentation inhibitors
11555210 · 2023-01-17 ·

Embodiments provide a modified microbe capable of growing in or fermenting a solution, or lignocellulosic hydrolysate, comprising ferulic acid and/or coniferyl aldehyde. The microbe has one or more modifications to provide: (a) a decrease in copy number or expression of a BNA7 gene; (b) an increase in copy number or expression of one or more pentose phosphate pathway genes; and/or (c) localization of one or more products of the pentose phosphate pathway genes to the mitochondria or endoplasmic reticulum. Also provided is a microbe having modified expression or copy number of BNA7 and/or one or more of the pentose phosphate pathway genes. The pentose phosphate pathway genes may in certain embodiments be selected from at least one of ZWF1, TKL1, RPE1 and GND1. Also provided is a method for fermenting a substrate comprising ferulic acid and/or coniferyl aldehyde to produce a fermentation product.

HIGH PURITY gRNA SYNTHESIS PROCESS
20230220379 · 2023-07-13 ·

The present disclosure relates to methods, compositions and kits for synthesizing moderate length RNAs (mlRNAs, including gRNAs) by splint-mediated ligation of RNA fragments. The synthesis of moderate length RNAs can be followed by DNase treatment. In some embodiments, splint DNA oligonucleotides that are no longer than 32 nucleotides are used.

Method of protein purification from <i>E.coli</i>
11697803 · 2023-07-11 · ·

The present disclosure provides methods for releasing intracellular proteins. The method allows isolation of the protein of interest from the cell without the requirement for mechanical disruption of the cells, without the need for isolation of the cells from the culture media, and without the need for removal of the cells from the culture media.

Method of protein purification from <i>E.coli</i>
11697803 · 2023-07-11 · ·

The present disclosure provides methods for releasing intracellular proteins. The method allows isolation of the protein of interest from the cell without the requirement for mechanical disruption of the cells, without the need for isolation of the cells from the culture media, and without the need for removal of the cells from the culture media.